Stocks were trying to post a further recovery on Wednesday. The Federal Reserve’s FOMC decision on interest rates is expected to be “no rate cut” and neutral statements ahead, and investors are still adjusting used to the Trump administration’s slew of new policies. Many investors and traders are still trying to decide how they want their assets positioned for 2025 and beyond. This is where the top analyst upgrades, downgrades and initiations can come into play.
Oggonomics searches the daily flow of analyst calls covering the upgrades and downgrades from Wall Street to look for new ideas in Wall Street research reports that might have otherwise been overlooked or missed. Short-term traders get a glimpse of immediate price reactions to news and to the analyst calls. Long-term investors get a picture of new buy, sell and hold ratings with targets looking a year out.
Oggonomics always reminds investors and its readers that no single analyst report should ever be the sole basis to buy or sell a stock. That decision to buy or sell, or hold or short sell, is up to each investor and the decision should be made with a financial advisor.
These are some of the top analyst upgrades and downgrades seen on Wednesday, January 29, 2025.
Apple Inc. (NASDAQ: AAPL) was downgraded to Perform from Outperform at Oppenheimer. Apple closed up 3.6% at $238.26 ahead of the call but the stock was down 1.1% at $235.50 ahead of Wednesday’s opening bell.
Boeing Co. (NYSE: BA) was reiterated at Underweight with price target raised to $103 from $98 at Wells Fargo. UBS reiterated its Buy rating and raised its price target to $217 from $208. S&P did not issue any ratings change but noted that it’s losses push out positive cash flow improvements. Boeing closed up 1.5% at $177.78 on Tuesday despite bad earnings that had already been telegraphed a week earlier.
Coinbase Global inc. (NASDAQ: COIN) was raised to Neutral from Underperform and its price target was raised to $290 from $250 (versus $281.82 close) at Mizuho.
Datadog, Inc. (NASDAQ: DDOG) was downgraded to Hold from Buy and its price target was cut to $140 from $165 (versus $151.89 close) at Stifel.
General Motors Company (NYSE: GM) fell 8.9% to $50.04 on Tuesday after earnings beat estimates but the CEO did not address tariff impacts on the 2025 guidance. GM was reiterated at Underweight and its price target was raised to $37 from $35 at Wells Fargo. BNP Paribas maintained its Positive rating and $67 target but warned that administration policy uncertainty may weigh on the stock. Mizuho reiterated its Buy rating and raised its target to $63 from $62.
Kinder Morgan, Inc. (NYSE: KMI) was reiterated at Neutral but its price target was raised to $28 from $25 (versus $27.46 close) at Citigroup.
MicroStrategy Incorporated (NASDAQ: MSTR) was initiated with an Outperform rating and was given a $515 price target (versus $335.93 close) at Mizuho.
Millicom International Cellular S.A. (NASDAQ: TIGO) was started as Equal-Weight with a $32 price target (versus $27.60 close) at Morgan Stanley.
Moderna, Inc. (NASDAQ: MRNA) was rose 7.9% to $44.94 on Tuesday vuut was indicated down almost 3% at $43.66 on Wednesday morning. Moderna was downgraded to Neutral from Buy and its price target was slashed down to $51 from $99 at Goldman Sachs.
NextEra Energy Partners, L.P. (NYSE: NEP) was reiterated at Equal-Weight and its price target was cut to $13 from $33 (versus $11.83 close) at Wells Fargo.
Nucor Corporation (NYSE: NUE) was reiterated at Hold and its price target raised to $135 from $125 at Jefferies.
Royal Caribbean Cruises Ltd. (NYSE: RCL) was reiterated as Buy and its target price was raised to $305 from $280 at Argus. RCL was reiterated as Buy and its price target was raised to $304 from $283 at Citigroup; RCL was reiterated at Overweight and its price target was raised to $297 from $272 at Wells Fargo. RCL was reiterated as Overweight and its price target was raised to $308 from $287 at Barclays. Royal Caribbean closed up 12% at $265.25 after earnings on Tuesday.
Sanmina Corporation (NASDAQ: SANM) was raised to Neutral from Underperform at BofA Securities.
Starbucks Corporation (NASDAQ: SBUX) closed up 0.4% at $100.41 ahead of earnings but Wednesday’s reaction was up 2.9% at $103.30 despite another quarter of negative sales trends. Starbucks was reiterated as Neutral and its price target was raised to $100 from $95 at Wedbush. Starbucks was reiterated at Overweight and its price target was raised to $124 from $119 at Barclays.
If you missed out on Tuesday’s top analyst calls, they were in shares of Albermarle, Astera, AT&T, Baidu, Ciena, Eli Lilly, Lululemon, Twilio, Uber and many more stocks.
